Demographic characteristics, lymphocytes count circulating of participants and tumors classification (n = 19).</p
<p>Demographic and clinical characteristics of the first 50 patients whose sera were evaluated.</p
Demographic and clinical characteristics of the study population (n = 1,747).</p
<p><sup>1</sup>Frequency (percentage of study participants for the category)</p><p>Study participant...
Demographic characteristics and lymphocytes counts circulating of Stage II participants (n = 8).</p
<p>Demographic information and tumor characteristics of patients included in genotyping ancillary st...
<p>Demographic and tumor characteristics for breast cancer patients with positive lymph nodes.</p
<p>TMAb = thyroid microsomal antibody; TGAb = thyroglobulin antibody; TSH = thyroid stimulating horm...
<p>Demographics and clinical characteristics of cancer and control (n = 726).</p
<p><sup>1</sup> all malignant lesions</p><p><sup>2</sup> invasive carcinomas.</p><p>Patient demograp...
<p>Clinical and hematological characteristics of population with NLR≤3.95 and NLR>3.95.</p
<p>Clinical characteristics of breast cancer, neuroblastoma and ovarian cancer study populations.</p
<p>Demographic characteristics of discovery tumor and UPPP normal tissue samples.</p
Demographic characteristics of participants who presented for blood donation and type of participant...
<p>Clinical-pathological characteristics of TNBC and ER+BC cases.</p><p>n- number of cases.</p
<p>Demographic characteristics of all study patients (patients with suspected TBM, n = 37).</p
<p>Demographic and clinical characteristics of the first 50 patients whose sera were evaluated.</p
Demographic and clinical characteristics of the study population (n = 1,747).</p
<p><sup>1</sup>Frequency (percentage of study participants for the category)</p><p>Study participant...
Demographic characteristics and lymphocytes counts circulating of Stage II participants (n = 8).</p
<p>Demographic information and tumor characteristics of patients included in genotyping ancillary st...
<p>Demographic and tumor characteristics for breast cancer patients with positive lymph nodes.</p
<p>TMAb = thyroid microsomal antibody; TGAb = thyroglobulin antibody; TSH = thyroid stimulating horm...
<p>Demographics and clinical characteristics of cancer and control (n = 726).</p
<p><sup>1</sup> all malignant lesions</p><p><sup>2</sup> invasive carcinomas.</p><p>Patient demograp...
<p>Clinical and hematological characteristics of population with NLR≤3.95 and NLR>3.95.</p
<p>Clinical characteristics of breast cancer, neuroblastoma and ovarian cancer study populations.</p
<p>Demographic characteristics of discovery tumor and UPPP normal tissue samples.</p
Demographic characteristics of participants who presented for blood donation and type of participant...
<p>Clinical-pathological characteristics of TNBC and ER+BC cases.</p><p>n- number of cases.</p
<p>Demographic characteristics of all study patients (patients with suspected TBM, n = 37).</p
<p>Demographic and clinical characteristics of the first 50 patients whose sera were evaluated.</p
Demographic and clinical characteristics of the study population (n = 1,747).</p
<p><sup>1</sup>Frequency (percentage of study participants for the category)</p><p>Study participant...